Certis Oncology Solutions

About:

Certis Oncology Solutions is a precision oncology and translational science company serving patients, oncologists and drug developers

Website: https://certisoncology.com/

Top Investors: Incite Ventures

Description:

Certis is a precision oncology and translational science company. Our product is Oncology Intelligence®—highly predictive therapeutic response data derived from advanced models of cancer. Certis partners with oncology therapeutics developers to help close the problematic translation gap between preclinical studies and clinical trials. Using CertisAI™, our proprietary artificial intelligence/machine learning platform, and more clinically relevant, patient-derived tumor models, we bring certainty to lead candidate selection and help secure clear and compelling evidence of drug efficacy. Certis is ALAAAC-accredited and CLIA-certified for high-complexity testing.

Total Funding Amount:

$10M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

San Diego, California, United States

Founded Date:

2016-01-01

Contact Email:

info(AT)certisoncology.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2024-01-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai